Trial intelligence / Profile preview

Metvix PDT for Photoaged Skin

NCT00437320Phase 2Completed

Sponsor
Galderma
Start
Apr 2007
Primary completion
Sep 2008
Modality
Light/Condition-Responsive Prodrugs
Countries
2
01

Overview

A Phase 2 trial of methyl aminolevulinate in skin photoaging, sponsored by Galderma. Started Apr 2007; status: completed.

02

Drugs

methyl aminolevulinate
03

Conditions

skin photoaging

Beyond the preview

Go deeper on NCT00437320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call